Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
Background More than 10 years have elapsed since human papillomavirus (HPV)
vaccination was implemented. We did a systematic review and meta-analysis of the …
vaccination was implemented. We did a systematic review and meta-analysis of the …
Sexually transmitted infections: challenges ahead
WHO estimated that nearly 1 million people become infected every day with any of four
curable sexually transmitted infections (STIs): chlamydia, gonorrhoea, syphilis, and …
curable sexually transmitted infections (STIs): chlamydia, gonorrhoea, syphilis, and …
The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?
C Patel, JML Brotherton, A Pillsbury… - …, 2018 - eurosurveillance.org
Background: A National human papilloma virus (HPV) Vaccination Programme for the
prevention of HPV infection and associated disease using the quadrivalent HPV vaccine …
prevention of HPV infection and associated disease using the quadrivalent HPV vaccine …
Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional …
K Kavanagh, KG Pollock, K Cuschieri… - The Lancet infectious …, 2017 - thelancet.com
Summary Background On Sept 1, 2008, Scotland launched routine vaccination for human
papillomavirus (HPV) types 16 and 18, targeted at 12–13-year-old girls, of whom 92· 4 …
papillomavirus (HPV) types 16 and 18, targeted at 12–13-year-old girls, of whom 92· 4 …
[HTML][HTML] Mapping information exposure on social media to explain differences in HPV vaccine coverage in the United States
Background Together with access, acceptance of vaccines affects human papillomavirus
(HPV) vaccine coverage, yet little is known about media's role. Our aim was to determine …
(HPV) vaccine coverage, yet little is known about media's role. Our aim was to determine …
Epidemiology and prevention of sexually transmitted infections in men who have sex with men at risk of HIV
Since 2012, the increasingly widespread promotion and uptake of HIV treatment as
prevention and pre-exposure prophylaxis in men who have sex with men has been …
prevention and pre-exposure prophylaxis in men who have sex with men has been …
Very low prevalence of vaccine human papillomavirus types among 18-to 35-year old Australian women 9 years following implementation of vaccination
DA Machalek, SM Garland… - The Journal of …, 2018 - academic.oup.com
Introduction A quadrivalent human papillomavirus vaccination program targeting females
aged 12–13 years commenced in Australia in 2007, with catch-up vaccination of 14–26 year …
aged 12–13 years commenced in Australia in 2007, with catch-up vaccination of 14–26 year …
Protocolo Brasileiro para Infecções Sexualmente Transmissíveis 2020: infecção pelo papilomavírus humano (HPV)
NS Carvalho, RJC Silva, IC Val… - … e Serviços de …, 2021 - SciELO Public Health
O artigo aborda a infecção pelo papilomavírus humano (human papillomavirus, HPV), tema
constitutivo do Protocolo Clínico e Diretrizes Terapêuticas para Atenção Integral às Pessoas …
constitutivo do Protocolo Clínico e Diretrizes Terapêuticas para Atenção Integral às Pessoas …
Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a …
EPF Chow, DA Machalek, SN Tabrizi… - The Lancet infectious …, 2017 - thelancet.com
Background Australia introduced a national quadrivalent human papillomavirus (4vHPV)
vaccination programme for girls and young women in April, 2007. The HPV genotypes …
vaccination programme for girls and young women in April, 2007. The HPV genotypes …
Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence
DR Brown, EA Joura, GP Yen, S Kothari… - Vaccine, 2021 - Elsevier
Background The extent of cross-protection provided by currently licensed bivalent and
quadrivalent HPV vaccines versus direct protection against HPV 31-, 33-, 45-, 52-, and 58 …
quadrivalent HPV vaccines versus direct protection against HPV 31-, 33-, 45-, 52-, and 58 …